334 related articles for article (PubMed ID: 25455840)
1. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute.
Otsuka M; Yamasaki O; Kaji T; Iwatsuki K; Asagoe K
J Dermatol; 2015 Oct; 42(10):954-61. PubMed ID: 26074328
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
5. "Gloves-and-socks" melanoma: does histology make a difference?
Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
[TBL] [Abstract][Full Text] [Related]
6. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
[TBL] [Abstract][Full Text] [Related]
7. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
White I; Fortino J; Curti B; Vetto J
Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
[TBL] [Abstract][Full Text] [Related]
9. Unique prognostic factors in acral lentiginous melanoma.
Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
[TBL] [Abstract][Full Text] [Related]
10. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
11. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
14. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
15. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
17. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
[TBL] [Abstract][Full Text] [Related]
18. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
Fujisawa Y; Otsuka F;
Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of microscopic tumor burden in sentinel lymph node in patients with cutaneous melanoma.
Kim C; Economou S; Amatruda TT; Martin JC; Dudek AZ
Anticancer Res; 2015 Jan; 35(1):301-9. PubMed ID: 25550564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
